个人中心
登出
中文简体
返回
-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
登录后咨询在线客服
回到顶部
12 Health Care Stocks Moving In Tuesday's Intraday Session
12 Health Care Stocks Moving In Tuesday's Intraday Session
周二盘中有12只医疗保健类股走势
Gainers
- Inhibrx (NASDAQ:INBX) stock rose 40.4% to $28.33 during Tuesday's regular session. Inhibrx's stock is trading at a volume of 5.4 million shares as of 13:30 EST. This is 1119.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.1 billion.
- Applied DNA Sciences (NASDAQ:APDN) stock moved upwards by 36.59% to $1.53. Trading volume for Applied DNA Sciences's stock is 5.2 million as of 13:30 EST. This is 70.7% of its average full-day volume over the last 100 days. The company's market cap stands at $19.7 million.
- Cue Biopharma (NASDAQ:CUE) stock rose 25.99% to $3.01. The current volume of 1.0 million shares is 661.7% of Cue Biopharma's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $106.5 million.
- Vapotherm (NYSE:VAPO) shares increased by 24.54% to $2.06. Trading volume for Vapotherm's stock is 202.1K as of 13:30 EST. This is 112.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $54.8 million.
- Autolus Therapeutics (NASDAQ:AUTL) stock moved upwards by 22.47% to $2.67. Trading volume for Autolus Therapeutics's stock is 517.4K as of 13:30 EST. This is 419.7% of its average full-day volume over the last 100 days. The company's market cap stands at $242.7 million.
- Immunovant (NASDAQ:IMVT) shares increased by 21.62% to $8.02. Trading volume for Immunovant's stock is 11.6 million as of 13:30 EST. This is 2257.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $934.3 million.
Losers
- Ampio Pharmaceuticals (AMEX:AMPE) shares declined by 66.8% to $0.02 during Tuesday's regular session. As of 13:30 EST, this security is trading at a volume of 34.6 million shares, making up 465.7% of its average full-day volume over the last 100 days. The company's market cap stands at $4.5 million.
- KalVista Pharma (NASDAQ:KALV) stock declined by 56.18% to $6.24. Trading volume for this security as of 13:30 EST is 4.0 million, which is 2357.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $153.5 million.
- Verastem (NASDAQ:VSTM) shares fell 31.4% to $0.6. Trading volume for this security as of 13:30 EST is 5.7 million, which is 474.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $112.6 million.
- Rallybio (NASDAQ:RLYB) stock decreased by 20.73% to $11.78. Trading volume for this security as of 13:30 EST is 69.9K, which is 146.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $378.5 million.
- Cryo-Cell International (AMEX:CCEL) shares fell 16.31% to $5.44. The company's market cap stands at $46.3 million.
- Connect Biopharma Hldgs (NASDAQ:CNTB) shares declined by 16.07% to $1.1. As of 13:30 EST, Connect Biopharma Hldgs's stock is trading at a volume of 2.6 million, which is 1002.9% of its average full-day volume over the last 100 days. The company's market cap stands at $60.4 million. See Also:
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Gainers
赢家
- Inhibrx (NASDAQ:INBX) stock rose 40.4% to $28.33 during Tuesday's regular session. Inhibrx's stock is trading at a volume of 5.4 million shares as of 13:30 EST. This is 1119.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.1 billion.
- Applied DNA Sciences (NASDAQ:APDN) stock moved upwards by 36.59% to $1.53. Trading volume for Applied DNA Sciences's stock is 5.2 million as of 13:30 EST. This is 70.7% of its average full-day volume over the last 100 days. The company's market cap stands at $19.7 million.
- Cue Biopharma (NASDAQ:CUE) stock rose 25.99% to $3.01. The current volume of 1.0 million shares is 661.7% of Cue Biopharma's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $106.5 million.
- Vapotherm (NYSE:VAPO) shares increased by 24.54% to $2.06. Trading volume for Vapotherm's stock is 202.1K as of 13:30 EST. This is 112.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $54.8 million.
- Autolus Therapeutics (NASDAQ:AUTL) stock moved upwards by 22.47% to $2.67. Trading volume for Autolus Therapeutics's stock is 517.4K as of 13:30 EST. This is 419.7% of its average full-day volume over the last 100 days. The company's market cap stands at $242.7 million.
- Immunovant (NASDAQ:IMVT) shares increased by 21.62% to $8.02. Trading volume for Immunovant's stock is 11.6 million as of 13:30 EST. This is 2257.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $934.3 million.
- Inhibrx纳斯达克股票代码:INBX在周二的例会上上涨了40.4%,至28.33美元。截至美国东部时间13:30,Inhibrx的股票交易量为540万股。这是过去100日平均全天成交量的1119.1%。他们流通股的市值为11亿美元。
- 应用DNA科学(纳斯达克代码:APDN)股价上涨36.59%,至1.53美元。截至美国东部时间13:30,应用DNA科学的股票成交量为520万股。这是过去100天全天平均成交量的70.7%。该公司的市值为1,970万美元。
- 提示生物咽喉纳斯达克股价上涨25.99%,至3.01美元。目前成交量为100万股,是Cue Biophma过去100日全天平均成交量的661.7%(最近一次更新于美国东部时间13:30)。该公司的市值为1.065亿美元。
- 汽温(纽约证券交易所代码:VAPO)股价上涨24.54%,至2.06美元。截至美国东部时间13:30,Vaptherm的股票交易量为202.1K。这是过去100日平均全天成交量的112.4%。他们流通股的市值为5480万美元。
- Autolus治疗公司纳斯达克(美国在线股票代码:AUTL)股价上涨22.47%,至2.67美元。截至美国东部时间13:30,Autolus Treateutics的股票成交量为517.4K。这是过去100日平均全天成交量的419.7%。该公司的市值为2.427亿美元。
- 免疫抗体纳斯达克(Tmall:IMVT)股价上涨21.62%,至8.02美元。截至美国东部时间13:30,免疫系统公司股票的交易量为1,160万股。这是过去100日平均全天成交量的2257.2%。他们流通股的市值为9.343亿美元。
Losers
失败者
- Ampio Pharmaceuticals (AMEX:AMPE) shares declined by 66.8% to $0.02 during Tuesday's regular session. As of 13:30 EST, this security is trading at a volume of 34.6 million shares, making up 465.7% of its average full-day volume over the last 100 days. The company's market cap stands at $4.5 million.
- KalVista Pharma (NASDAQ:KALV) stock declined by 56.18% to $6.24. Trading volume for this security as of 13:30 EST is 4.0 million, which is 2357.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $153.5 million.
- Verastem (NASDAQ:VSTM) shares fell 31.4% to $0.6. Trading volume for this security as of 13:30 EST is 5.7 million, which is 474.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $112.6 million.
- Rallybio (NASDAQ:RLYB) stock decreased by 20.73% to $11.78. Trading volume for this security as of 13:30 EST is 69.9K, which is 146.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $378.5 million.
- Cryo-Cell International (AMEX:CCEL) shares fell 16.31% to $5.44. The company's market cap stands at $46.3 million.
- Connect Biopharma Hldgs (NASDAQ:CNTB) shares declined by 16.07% to $1.1. As of 13:30 EST, Connect Biopharma Hldgs's stock is trading at a volume of 2.6 million, which is 1002.9% of its average full-day volume over the last 100 days. The company's market cap stands at $60.4 million. See Also:
- Ampio制药公司(美国证券交易所股票代码:AMPE)股价在周二的例会中下跌66.8%,至0.02美元。截至美国东部时间13:30,该证券成交量为3,460万股,占其过去100日全天平均成交量的465.7。该公司的市值为450万美元。
- 卡尔维斯塔制药公司纳斯达克(Tmall:KALV)股价下跌56.18%,至6.24美元。截至美国东部时间13:30,该证券的成交量为400,000,000,是过去100日全天平均成交量的2357.4。他们流通股的市值为1.535亿美元。
- 维拉斯蒂纳斯达克(Tmall:VSTM)股价下跌31.4%,至0.6美元。截至美国东部时间13:30,该证券的成交量为570万美元,是过去100日全天平均成交量的474.9。他们流通股的市值为1.126亿美元。
- 拉里比奥纳斯达克(Sequoia Capital:RLYB)股价下跌20.73%,至11.78美元。截至美国东部时间13:30,该证券的成交量为69.9K,是过去100日全天平均成交量的146.4。他们流通股的市值为3.785亿美元。
- 国际冷冻细胞公司美国证券交易所股票代码:CCEL股价下跌16.31%,至5.44美元。该公司的市值为4630万美元。
- 康乃德生物纳斯达克股票代码:CNTB)股价下跌16.07%,至1.1美元。截至美国东部时间13:30,康乃德生物Hldgs的股票成交量为260万股,是其过去100日平均全天成交量的1002.9。该公司的市值为6,040万美元。另见:
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成,并由编辑审阅。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
风险及免责提示
本页的译文内容由软件翻译。Moomoo将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。
本内容仅用作提供信息及教育之目的,不构成对任何特定证券或投资策略的推荐或认可。本内容中的信息仅用于说明目的,可能不适用于所有投资者。本内容未考虑任何特定人士的投资目标、财务状况或需求,并不应被视作个人投资建议。建议您在做出任何投资于任何资本市场产品的决定之前,应考虑您的个人情况判断信息的适当性。过去的投资表现不能保证未来的结果。投资涉及风险和损失本金的可能性。moomoo对上述内容的真实性、完整性、准确性或对任何特定目的的时效性不做任何陈述或保证。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
知道了
风险及免责提示
本页的译文内容由软件翻译。Moomoo将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。
本内容仅用作提供信息及教育之目的,不构成对任何特定证券或投资策略的推荐或认可。本内容中的信息仅用于说明目的,可能不适用于所有投资者。本内容未考虑任何特定人士的投资目标、财务状况或需求,并不应被视作个人投资建议。建议您在做出任何投资于任何资本市场产品的决定之前,应考虑您的个人情况判断信息的适当性。过去的投资表现不能保证未来的结果。投资涉及风险和损失本金的可能性。moomoo对上述内容的真实性、完整性、准确性或对任何特定目的的时效性不做任何陈述或保证。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
知道了
抢沙发
0 0 0
赞大爱笑哭社会社会Emm心碎怒
轻触选择心情
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧
点击这里分享给好友
暂无评论,快来抢沙发吧!